NCT04322448View on ClinicalTrials.gov

Mechanomyography for Predictor of Prognosis in CuTS and PND Patients

CompletedOBSERVATIONAL
Enrollment

23

Participants

Timeline

Start Date

August 3, 2020

Primary Completion Date

July 5, 2022

Study Completion Date

February 17, 2023

Conditions
Cubital Tunnel SyndromePeroneal Nerve Entrapment
Interventions
DEVICE

Mechanomyography (MMG)

MMG, as described in the cohort descriptions, to be used during surgery to see if they are predictive of patient outcomes.

Trial Locations (2)

55905

Mayo Clinic, Rochester

63110

Washington University in St. Louis, St Louis

Sponsors

Collaborators (1)

Mayo Clinic
All Listed Sponsors
collaborator

Mayo Clinic

OTHER

lead

Washington University School of Medicine

OTHER

NCT04322448 - Mechanomyography for Predictor of Prognosis in CuTS and PND Patients | Biotech Hunter | Biotech Hunter